中文产业新闻精选评分72Chinese source
BioNTech BNT113联合帕博利珠单抗AHEAD-MERIT 2/3期首批顶线未达PFS主要终点
BioNTech mRNA癌症疫苗首个3期失败！
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
BioNTech mRNA癌症疫苗首个3期失败！
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.